Chengdu Easton Biopharmaceuticals Co Ltd
SSE:688513

Watchlist Manager
Chengdu Easton Biopharmaceuticals Co Ltd Logo
Chengdu Easton Biopharmaceuticals Co Ltd
SSE:688513
Watchlist
Price: 35.07 CNY -3.55% Market Closed
Market Cap: 6.2B CNY
Have any thoughts about
Chengdu Easton Biopharmaceuticals Co Ltd?
Write Note

Income Statement

Earnings Waterfall
Chengdu Easton Biopharmaceuticals Co Ltd

Revenue
1.2B CNY
Cost of Revenue
-254.9m CNY
Gross Profit
899.4m CNY
Operating Expenses
-679.3m CNY
Operating Income
220.1m CNY
Other Expenses
20.5m CNY
Net Income
240.6m CNY

Income Statement
Chengdu Easton Biopharmaceuticals Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024
Revenue
Revenue
1 071
N/A
1 100
+3%
1 147
+4%
1 171
+2%
1 179
+1%
1 150
-2%
1 123
-2%
1 117
0%
1 154
+3%
Gross Profit
Cost of Revenue
(180)
(190)
(201)
(198)
(219)
(224)
(234)
(226)
(255)
Gross Profit
891
N/A
910
+2%
946
+4%
972
+3%
960
-1%
926
-4%
888
-4%
891
+0%
899
+1%
Operating Income
Operating Expenses
(687)
(690)
(744)
(750)
(727)
(703)
(664)
(687)
(679)
Selling, General & Administrative
(542)
(544)
(561)
(569)
(559)
(534)
(494)
(478)
(496)
Research & Development
(204)
(206)
(218)
(217)
(236)
(238)
(234)
(219)
(243)
Depreciation & Amortization
0
0
0
(29)
0
0
0
(43)
0
Other Operating Expenses
59
60
35
65
68
69
65
53
59
Operating Income
203
N/A
221
+8%
203
-8%
222
+10%
233
+5%
224
-4%
225
+0%
205
-9%
220
+8%
Pre-Tax Income
Interest Income Expense
51
44
46
38
38
35
36
37
33
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
Gain/Loss on Disposition of Assets
0
0
0
(0)
0
0
0
(0)
0
Total Other Income
3
3
8
1
1
1
1
0
(0)
Pre-Tax Income
257
N/A
267
+4%
257
-4%
262
+2%
273
+4%
260
-5%
262
+1%
242
-8%
253
+5%
Net Income
Tax Provision
(14)
(17)
(15)
(15)
(19)
(17)
(17)
(15)
(13)
Income from Continuing Operations
243
250
242
247
254
243
245
227
241
Net Income (Common)
243
N/A
250
+3%
242
-3%
247
+2%
254
+3%
243
-4%
245
+1%
227
-7%
241
+6%
EPS (Diluted)
2.02
N/A
2.08
+3%
2.01
-3%
2.05
+2%
2.11
+3%
2.03
-4%
2.04
+0%
1.89
-7%
2.01
+6%

See Also

Discover More